Consort Medical PLC Director/PDMR Shareholding (7672I)
June 21 2017 - 7:10AM
UK Regulatory
TIDMCSRT
RNS Number : 7672I
Consort Medical PLC
21 June 2017
Consort Medical plc
Director Shareholding
21 June 2017
Consort Medical plc (the 'Company') announces that Paul Hayes,
Chief Financial Officer purchased 4,000 ordinary 10p shares at a
price of GBP10.9445 per share on 20 June 2017. Following this
transaction Mr Hayes holds 8,000 ordinary shares in the
Company.
The Notification of Dealing Form set out below is provided in
accordance with the requirements of the Market Abuse
Regulation.
1 Details of the person discharging managerial
responsibilities / person closely associated
---- -----------------------------------------------------------------
a) Name Paul Hayes
---- ----------------------------- ----------------------------------
2 Reason for the notification
---- -----------------------------------------------------------------
a) Position/status Chief Financial Officer
---- ----------------------------- ----------------------------------
b) Initial notification Initial Notification
/Amendment
---- ----------------------------- ----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- -----------------------------------------------------------------
a) Name Consort Medical plc
---- ----------------------------- ----------------------------------
b) LEI 2138001TBP74FD66QT38
---- ----------------------------- ----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- -----------------------------------------------------------------
a) Description of Ordinary Shares of 10p each
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Acquisition
transaction
---- ----------------------------- ----------------------------------
c) Price(s) and volume(s)
---- ----------------- ------------
Price(s) Volume(s)
---- ----------------- ------------
GBP10.9445 4,000
---------------------------------------------------- ------------
d) Aggregated information
----
n/a single transaction
- Aggregated volume
- Price
e) Date of the transaction 2017-06-20
---- ----------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange Main
Market (XLon)
---- ----------------------------- ----------------------------------
Enquiries: Michelle Palmer, Assistant Company Secretary 01442
8867920
Consort Medical plc is a leading, global, single source pharma
services drug and delivery device company. We are at the leading
edge of innovation and we are committed to investing in patient,
clinician and customer driven innovation to create new treatments,
new markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug
delivery devices for pharmaceutical partner companies, including
respiratory, nasal, injectables and ocular products, and the
manufacture of devices for the point of care diagnostics market.
www.bespak.com.
Aesica is a leading provider of finished dose and active
pharmaceutical ingredient (API) development and manufacturing
services to pharmaceutical partners. www.aesica-pharma.com.
We employ more than 2000 people globally of which 1400 are
located in the UK. We have UK facilities in King's Lynn, Cambridge,
Nelson, Milton Keynes, Cramlington, Queenborough and Hemel
Hempstead, German facilities in Monheim and Zwickau and a facility
in Pianezza, Italy. Consort Medical is a public company quoted on
the premium list of the London Stock Exchange (LSE: CSRT).
www.consortmedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFFLFLDQFBBBK
(END) Dow Jones Newswires
June 21, 2017 07:10 ET (11:10 GMT)
Consort Medical (LSE:CSRT)
Historical Stock Chart
From Apr 2024 to May 2024
Consort Medical (LSE:CSRT)
Historical Stock Chart
From May 2023 to May 2024